EUVIMEDEUVIMED entdecken
Open Access

Identification of Terminal βGlcNAc on Brachyspira Species in Human Intestinal Spirochetosis

Hisanori Matoba iD, Mai Iwaya iD, Chifumi Fujii iD, Jun Nakayama iD

Journal of Histochemistry & Cytochemistry · 2024

DOI: 10.1369/00221554231222963 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Histochemistry & Cytochemistry, 2024. Verfasst von Hisanori Matoba und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infection and Host Defense (HM); Department of Molecular Pathology (HM, CF, JN); Center for Medical Education and Clinical Training (CF…. Hauptthemen laut MEDLINE: Brachyspira, Spirochaetales Infections, Intestinal Diseases. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, National Institute on Drug Abuse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human intestinal spirochetosis (HIS) is a colorectal bacterial infection caused by the Brachyspira species. Griffonia simplicifolia-II (GS-II) is a lectin specific to terminal α/βGlcNAc residues. Here, we investigated terminal βGlcNAc residues in the context of HIS infection using GS-II-horseradish peroxidase staining and HIK1083 immunostaining specific to terminal αGlcNAc residues. Fourteen of 15 HIS cases were GS-II-positive on the bacterial body. No cases showed HIK1083 positivity. The percentage of bacterial bodies staining positively for GS-II based on comparison with anti- Treponema immunostaining was ≤30% in seven cases, 30–70% in two, and >70% in six. Of 15 HIS cases analyzed, none were comorbid with tubular adenomas, and three were comorbid with sessile serrated lesions (SSLs). To determine the species of spirochete infected, the B. aalborgi-specific or B. pilosicoli-specific NADPH oxidase genes were amplified by PCR. After direct sequencing of the PCR products, all nine cases in which PCR products were observed were found to be infected with B. aalborgi alone. These results indicate that the HIS bacterial body, especially of B. aalborgi, is characterized by terminal βGlcNAc and also indicate that terminal βGlcNAc on the HIS bacterial body is associated with HIS preference for SSLs:

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrachyspiraSpirochaetales InfectionsIntestinal DiseasesHumansIntestinesSpirochaetales

Stichwörter der Autor:innen

GS-IIhuman intestinal spirochetosis (HIS)sessile serrated lesion (SSL)βGlcNAc

Autor:innen und Institutionen

  • Department of Infection and Host Defense (HM); Department of Molecular Pathology (HM, CF, JN); Center for Medical Education and Clinical Training (CF), Shinshu University School of Medicine, Matsumoto, Japan; Department…

ORCID-Profile: Hisanori Matoba, Mai Iwaya, Chifumi Fujii, Jun Nakayama

Förderung

  • NIDA NIH HHS
  • National Institute on Drug Abuse

Zitieren

APA

Matoba, H., Iwaya, M., Fujii, C., & Nakayama, J. (2024). Identification of Terminal βGlcNAc on Brachyspira Species in Human Intestinal Spirochetosis. Journal of Histochemistry & Cytochemistry. https://doi.org/10.1369/00221554231222963

Vancouver

Matoba H, Iwaya M, Fujii C, Nakayama J. Identification of Terminal βGlcNAc on Brachyspira Species in Human Intestinal Spirochetosis. Journal of Histochemistry & Cytochemistry. 2024. doi:10.1369/00221554231222963

BibTeX
@article{Matoba2024,
  author = {Matoba, Hisanori and Iwaya, Mai and Fujii, Chifumi and Nakayama, Jun},
  title = {Identification of Terminal βGlcNAc on Brachyspira Species in Human Intestinal Spirochetosis},
  journal = {Journal of Histochemistry & Cytochemistry},
  year = {2024},
  doi = {10.1369/00221554231222963}
}
Kostenlos starten →